Literature DB >> 16955065

Efficacy of the symmetric, patient-oriented, rigid, three-dimensional, active (SPoRT) concept of bracing for scoliosis: a prospective study of the Sforzesco versus Lyon brace.

S Negrini1, G Marchini.   

Abstract

AIM: Bracing is considered to be effective in the treatment of adolescent idiopathic scoliosis. The concept prevailing today includes an asymmetrical construction, mainly using a mechanical three-point system. We developed the new Sforzesco brace, based on the SPoRT concept (Symmetric, Patient-oriented, Rigid, Three-dimensional, active). The aim of this study is to verify the results of this concept and brace, compared to three-point classical systems.
METHODS: We performed a prospective, pair-controlled study. It was possible to match 15 patients, out of the first 18 consecutively treated with the Sforzesco brace (Group SPoRT), with previous patients treated with the Lyon brace (Group LY). SPoRT included 14.2+/-1.7 year old patients, with 47+/-7 degrees Cobb worst curves, and 11+/-4 degrees Bunnell; LY included 13.6+/-1.6 year old patients, with 43+/-7 degrees Cobb and 12+/-5 degrees Bunnell. The brace had to be worn 23 h per day and patients were evaluated after 6 months both clinically and radiographically (without the brace). Appropriate statistics were used.
RESULTS: At the baseline there were slight differences between the groups, with SPoRT worse than LY. All radiographic and clinical parameters decreased significantly with treatment in both groups, apart from thoracic Cobb degrees in LY. SPoRT had better results than LY (P<0.05) radiographically (worst curve -10+/-5 degrees vs -5+/-7 degrees, all curves -8+/-7 degrees vs -6+/-7 degrees), for sagittal profile (distance from plumbline: T12 -6+/-9 mm vs +2+/-8 and L3 -7+/-12 vs 0+/-10) and aesthetics of the shoulders (9 improved and 6 unchanged vs 5 and 8) and waists (10 improved and 5 unchanged vs 5 and 8). Finally, clinical results in terms of patient recovery were better in SPoRT than LY (12 improved and 3 unchanged vs 8 and 5).
CONCLUSION: When a new treatment is introduced, it is not possible to wait years (end of therapy) before verifying its utility, and in scoliosis bracing a short term study already gives very important clues. This study confirms the immediate efficacy of brace treatment (even in such high degree cases) whatever the brace concept used, with only 2 (out of 30) progressed curves. In SPoRT we had no progressions, and obtained a statistically significant 80% better radiographic results than LY in the worst scoliosis curve, and 40% in the average of all curves, as well as improved aesthetics and sagittal profile (that is crucial in scoliosis bracing). The Sforzesco brace should be used, and the SPoRT concept explored in the long term to verify if the classical three-point system should be totally (or partially) abandoned.

Entities:  

Mesh:

Year:  2006        PMID: 16955065

Source DB:  PubMed          Journal:  Eura Medicophys        ISSN: 0014-2573


  22 in total

1.  Introduction to the "Scoliosis" Journal Brace Technology Thematic Series: increasing existing knowledge and promoting future developments.

Authors:  Stefano Negrini; Theodoros B Grivas
Journal:  Scoliosis       Date:  2010-01-28

Review 2.  Finite element analysis in brace treatment on adolescent idiopathic scoliosis.

Authors:  Wenqing Wei; Tianyuan Zhang; Zifang Huang; Junlin Yang
Journal:  Med Biol Eng Comput       Date:  2022-02-14       Impact factor: 2.602

3.  Preference assessment of recruitment into a randomized trial for adolescent idiopathic scoliosis.

Authors:  Lori A Dolan; Vani Sabesan; Stuart L Weinstein; Kevin F Spratt
Journal:  J Bone Joint Surg Am       Date:  2008-12       Impact factor: 5.284

Review 4.  2016 SOSORT guidelines: orthopaedic and rehabilitation treatment of idiopathic scoliosis during growth.

Authors:  Stefano Negrini; Sabrina Donzelli; Angelo Gabriele Aulisa; Dariusz Czaprowski; Sanja Schreiber; Jean Claude de Mauroy; Helmut Diers; Theodoros B Grivas; Patrick Knott; Tomasz Kotwicki; Andrea Lebel; Cindy Marti; Toru Maruyama; Joe O'Brien; Nigel Price; Eric Parent; Manuel Rigo; Michele Romano; Luke Stikeleather; James Wynne; Fabio Zaina
Journal:  Scoliosis Spinal Disord       Date:  2018-01-10

5.  In defense of adolescents: They really do use braces for the hours prescribed, if good help is provided. Results from a prospective everyday clinic cohort using thermobrace.

Authors:  Sabrina Donzelli; Fabio Zaina; Stefano Negrini
Journal:  Scoliosis       Date:  2012-05-31

6.  Adolescent idiopathic scoliosis: Indications and efficacy of nonoperative treatment.

Authors:  Federico Canavese; André Kaelin
Journal:  Indian J Orthop       Date:  2011-01       Impact factor: 1.251

7.  Brace technology thematic series - The Sforzesco and Sibilla braces, and the SPoRT (Symmetric, Patient oriented, Rigid, Three-dimensional, active) concept.

Authors:  Stefano Negrini; Gianfranco Marchini; Fabrizio Tessadri
Journal:  Scoliosis       Date:  2011-05-09

8.  2011 SOSORT guidelines: Orthopaedic and Rehabilitation treatment of idiopathic scoliosis during growth.

Authors:  Stefano Negrini; Angelo G Aulisa; Lorenzo Aulisa; Alin B Circo; Jean Claude de Mauroy; Jacek Durmala; Theodoros B Grivas; Patrick Knott; Tomasz Kotwicki; Toru Maruyama; Silvia Minozzi; Joseph P O'Brien; Dimitris Papadopoulos; Manuel Rigo; Charles H Rivard; Michele Romano; James H Wynne; Monica Villagrasa; Hans-Rudolf Weiss; Fabio Zaina
Journal:  Scoliosis       Date:  2012-01-20

9.  The Sforzesco brace can replace cast in the correction of adolescent idiopathic scoliosis: A controlled prospective cohort study.

Authors:  Stefano Negrini; Salvatore Atanasio; Francesco Negrini; Fabio Zaina; Gianfranco Marchini
Journal:  Scoliosis       Date:  2008-10-31

10.  Effectiveness of complete conservative treatment for adolescent idiopathic scoliosis (bracing and exercises) based on SOSORT management criteria: results according to the SRS criteria for bracing studies - SOSORT Award 2009 Winner.

Authors:  Stefano Negrini; Salvatore Atanasio; Claudia Fusco; Fabio Zaina
Journal:  Scoliosis       Date:  2009-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.